Tag Archives: ALXN

Video: Celgene, Alexion Earnings Top, But Stocks Fall

Big-cap biotechs Celgene (CELG) and Alexion Pharmaceuticals (ALXN) both modestly beat Q2 estimates and raised their guidance Thursday morning, but their shares were falling in the stock market today as Wall Street seemed to hope for more. Celgene’s Q2 earnings rose 18% over the year-earlier quarter to 90 cents a share, beating consensus by a penny. Sales increased 17% to $1.87 billion, about $20 million above estimates. The company added $100

Video: Celgene, Alexion Earnings Top Street, But Stocks Fall

Big-cap biotechs Celgene (CELG) and Alexion Pharmaceuticals (ALXN) both modestly beat Q2 estimates and raised their guidance Thursday morning, but their shares were falling in the stock market today as Wall Street seemed to hope for more. Celgene’s Q2 earnings rose 18% over the year-earlier quarter to 90 cents a share, beating consensus by a penny. Sales increased 17% to $1.87 billion, about $20 million above estimates. The company added $100

Alexion, Celgene Report Contrasting Q1 Earnings

Big-cap biotech Alexion Pharmaceuticals (ALXN) beat Q1 estimates and raised its full-year-earnings guidance Thursday, sending the stock up 3% in morning trading on the stock market. Fellow biotech giant Celgene (CELG) missed, however. Alexion reported earnings of $1.53 a share, up 135% from the year-earlier quarter and 27 cents above analysts’ consensus. Sales rose 67% to $566.6 million, topping estimates by nearly $7 million. For this year, the